What Research Shows About Automated Insulin Delivery for Kids and Teens

Automated insulin delivery systems represent a significant shift in how insulin is managed. Rather than relying on manual insulin injections or pump adjustments, these systems continuously monitor blood sugar through a glucose sensor and use a computer algorithm to automatically adjust insulin delivery in real time. This automation is particularly important for children and adolescents, whose insulin needs can vary unpredictably throughout the day due to activity, growth, food intake, and other factors.

Researchers reviewed 10 randomized controlled trials—the gold standard for medical evidence—involving 888 children and adolescents with Type 1 diabetes, aged 1 to 18 years. When studies measured how much time participants spent in their target blood sugar range, those using AID systems spent significantly more time there than those using traditional insulin therapy.

The improvement ranged from 8.7 to 12.4 percentage points more time in range, which translates to roughly two to three additional hours per day with blood sugar in the target zone. The strongest results were seen in younger children, specifically those aged 2 to under 6 years, suggesting that AID may be particularly effective during early childhood.

HbA1c is a three-month average of blood sugar levels and is a key measure of long-term diabetes control. In trials where HbA1c was the primary measure, participants using AID had reductions of 0.32% to 0.5% compared to those using non-automated therapy. While these may seem like small numbers, they reflect meaningful improvements in overall glycemic control.

The research also noted that the greatest absolute benefits were seen in participants who started furthest from their target HbA1c range, meaning those who needed the most improvement showed the largest gains.

An important question for any diabetes technology is whether it increases the risk of hypoglycemia (low blood sugar). This systematic review found that hypoglycemia exposure was not increased in participants using AID systems, suggesting that automated insulin delivery can improve time in range without making dangerous low blood sugar episodes more common.

This comprehensive review of rigorous clinical trials provides strong evidence that automated insulin delivery systems can help children and adolescents achieve better blood sugar control. The benefits extend across age groups, though younger children may see the most dramatic improvements.

If you're considering whether an AID system might be right for your child, these findings can help inform conversations with your diabetes care team. Every child's situation is different, and your healthcare provider can discuss whether an AID system is appropriate, what options are available, and how to use it effectively as part of your family's diabetes management plan.

Source: Cureus. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.